Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”), and BGF join existing investors Cambridge Innovation Capital, DDF, M Ventures, Pfizer Ventures, Eli Lilly and Company, MP Healthcare Venture Management (MPH), Cambridge Enterprise Ventures
At Insmed, every moment and every patient counts — and so does every person who joins in. As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you’ll be part of a community that prioritizes the human experience, celebrates curiosity, and values every person’s contributions to meaningful progress. That commitment has earned us recognition as Science magazine’s No.
The Vacancy
The Communications team is responsible for informing, inspiring and engaging the public by showcasing Alzheimer’s Research UK’s work, impact and mission across all channels. We lead the charity’s media and strategic communications activity—ensuring consistent, accurate and compelling storytelling that supports research, fundraising and organisational priorities.
Applications are invited for a Project Scientist to join the Laboratory of Prof Hildebrand in the Gut Microbes and Health programme at Quadram Institute Bioscience (QIB), based in Norwich, UK.
Background:
The Hildebrand lab uses metagenomics, molecular microbiology and high-throughput sequencing to study microbial communities in human and environmental systems. Our work asks how microbes colonise new environments, persist over time, and change in response to host, family and environmental factors.
An exciting opportunity has arisen for a Postdoctoral Researcher in Bioinformatics to join the Saunders Group at the John Innes Centre, working on cutting-edge science in plant disease diagnostics.
About the Saunders Group
The Saunders group works on a variety of emerging and re-emerging plant pathogens using a broad array of techniques that includes molecular genetics, biochemistry, plant pathology, cell biology, genomics, transcriptomics, and data mining to improve our understanding of the molecular mechanisms at the plant pathogen interface.
LONDON, UK, ZUG, Switzerland and STOCKHOLM, Sweden – June 23, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Cellcolabs and is pleased to announce the placement of Vincent Metzler, Ph.D., as Chief Executive Officer (CEO).
About Vernalis
Working within our fully equipped research laboratories in Cambridge, our established group of scientists are world leaders in multiple hit-ID technologies and structure-based drug discovery.
Our scientists leverage cutting-edge lead generation and structure-based design to unlock new possibilities in drug discovery, advancing innovative compounds towards development candidates across diverse therapeutic areas, including oncology, neurodegeneration, anti-infectives and inflammation.
The Role – job Summary
by Alicia Gailliez, Business Development Manager, One Nucleus
Community drives motivation, which helps to create action.
Nuclera is a venture-backed, founder-driven biotech company headquartered in Cambridge, UK with significant operations in Boston, USA. The company’s mission is to improve human health by making proteins accessible. We are beginning this mission through the launch of our eProtein Discovery™ platform. eProtein Discovery is a breakthrough protein expression, characterization, and purification technology, consisting of a lab-based benchtop instrument, cloud-based software and proprietary cartridges and consumables.
At Cancer Research UK, we exist to beat cancer.
We have an exciting opportunity for a commercially minded individual to join our Operations team in Cambridge. In this role, you will provide essential support to the Therapeutic Innovation (TI) Operations team, playing a key part in managing contract documentation, coordinating approvals, maintaining compliance, and supporting the administration of supplier agreements.